SOTKMEDIUM SIGNALFINANCIAL10-K

SOTK experienced meaningfully reduced operating cash flow alongside declining profitability, though inventory management improved and receivables grew substantially.

The significant deterioration in operating cash flow generation despite maintaining reasonable profitability suggests potential working capital management challenges or timing issues with collections. The substantial growth in accounts receivable could indicate either business expansion or emerging collection difficulties that warrant monitoring.

Comparing 2025-05-28 vs 2024-05-23View on EDGAR →
FINANCIAL ANALYSIS

SOTK's financial position shows mixed signals with accounts receivable growing substantially to $2.3M and total debt increasing moderately to $1.0M, while overall liabilities declined meaningfully to $5.6M. Operating performance weakened with operating cash flow declining substantially to $525K and operating income dropping to $1.0M. The company demonstrated improved inventory management with levels declining to $4.5M, though the disconnect between receivables growth and cash flow generation suggests potential working capital timing issues.

FINANCIAL STATEMENT CHANGES
Accounts Receivable
Balance Sheet
+59.6%
$1.5M$2.3M

Receivables surged 59.6% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Operating Cash Flow
Cash Flow
-54.9%
$1.2M$525K

Operating cash flow fell 54.9% — earnings quality concerns; investigate working capital changes and non-cash items.

Total Debt
Balance Sheet
+41.5%
$708K$1.0M

Debt increased 41.5% — substantial leverage increase; assess whether deployed for growth or covering losses.

Capital Expenditure
Cash Flow
-41%
$795K$469K

Capex reduced 41% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Interest Expense
P&L
+20.6%
$33K$40K

Interest costs rose 20.6% — monitor debt levels and coverage ratio in rising rate environment.

Total Liabilities
Balance Sheet
-18%
$6.9M$5.6M

Liabilities reduced 18% — deleveraging improves balance sheet strength and financial flexibility.

Current Liabilities
Balance Sheet
-17.2%
$6.6M$5.5M

Current liabilities reduced — improved short-term financial position and working capital health.

Operating Income
P&L
-14.6%
$1.2M$1.0M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Inventory
Balance Sheet
-14.3%
$5.2M$4.5M

Inventory reduced 14.3% — lean inventory management or demand outpacing supply.

LANGUAGE CHANGES
NEW — 2025-05-28
PRIOR — 2024-05-23
ADDED
We refer to the fiscal year ended February 28, 2025 as fiscal 2025 and use similar protocol for previous fiscal years.
Generally, except in instances of pandemic related supply chain issues, all raw materials used in our products are available from many different domestic suppliers, who may themselves be subject to international raw material availability.
We carefully manage our inventory using lean manufacturing processes.
During fiscal 2025 and fiscal 2024, we spent $2,724,000 and $2,886,000, respectively, on research and development activities related to new products and services and the ongoing improvement of existing products and services.
As a percentage of sales, research and development expenses were 13.3% and 14.6% in fiscal 2025 and 2024, respectively.
+7 more — sign up free →
REMOVED
We refer to the fiscal year ended February 29, 2024 as fiscal 2024 and use similar protocol for previous fiscal years.
Generally, except in instances of pandemic related supply chain issues, all raw materials used in our products are available from many different domestic suppliers.
When materials are plentiful, we carefully manage our inventory using lean manufacturing processes.
We provide a limited warranty on all of our products that covers parts and labor for a period of one year from the date of sale .
During fiscal 2024 and fiscal 2023, we spent $2,886,000 and $2,149,000, respectively, on research and development activities related to new products and services and the ongoing improvement of existing products and services.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →